Cited by 1,442Folate and B Vitamins ResearchAcute Myocardial Infarction ResearchLipoproteins and Cardiovascular Health

Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction

Open access
Bønaa, Kaare Harald, Njølstad, Inger, Ueland, Per Magne, Schirmer, Henrik, Tverdal, Aage, Steigen, Terje, Wang, Harald, Nordrehaug, Jan Erik +2 more·2006·New England Journal of Medicine

Abstract

BACKGROUND: Homocysteine is a risk factor for cardiovascular disease. We evaluated the efficacy of homocysteine-lowering treatment with B vitamins for secondary prevention in patients who had had an acute myocardial infarction. METHODS: The trial included 3749 men and women who had had an acute myocardial infarction within seven days before randomization. Patients were randomly assigned, in a two-by-two factorial design, to receive one of the following four daily treatments: 0.8 mg of folic acid, 0.4 mg of vitamin B12, and 40 mg of vitamin B6; 0.8 mg of folic acid and 0.4 mg of vitamin B12; 40 mg of vitamin B6; or placebo. The primary end point during a median follow-up of 40 months was a composite of recurrent myocardial infarction, stroke, and sudden death attributed to coronary artery disease. RESULTS: The mean total homocysteine level was lowered by 27 percent among patients given folic acid plus vitamin B12, but such treatment had no significant effect on the primary end point (risk ratio, 1.08; 95 percent confidence interval, 0.93 to 1.25; P=0.31). Also, treatment with vitamin B6 was not associated with any significant benefit with regard to the primary end point (relative risk of the primary end point, 1.14; 95 percent confidence interval, 0.98 to 1.32; P=0.09). In the group given folic acid, vitamin B12, and vitamin B6, there was a trend toward an increased risk (relative risk, 1.22; 95 percent confidence interval, 1.00 to 1.50; P=0.05). CONCLUSIONS: Treatment with B vitamins did not lower the risk of recurrent cardiovascular disease after acute myocardial infarction. A harmful effect from combined B vitamin treatment was suggested. Such treatment should therefore not be recommended. (ClinicalTrials.gov number, NCT00266487.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa055227

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. Davey Smith G, Ebrahim S. 'Mende- lian randomization': can genetic epidemi- ology contribute to understanding envi- ronmental determinants of disease? Int J Epidemiol 2003;32:1-22.
  2. Robinson K, Arheart K, Refsum H, et al. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. Circulation 1998;97:437-43. [Erratum, Circulation 1999;99:983.
  3. www.nejm.org april 13, 2006 The New England Journal of Medicine Downloaded from nejm.org on August 29, 2023. For personal use only. No other uses without permission. Copyright © 2006 Massachusetts Medical Society. All rights reserved. n engl j med 354;15
  4. www.nejm.org april 13, 2006 1588 homocysteine lowering after acute myocardial infarction ing on resistance vessel reactivity in ath- erosclerotic subjects. J Pharmacol Exp Ther 2002;303:158-62.
  5. Faraci FM, Lentz SR. Hyperhomocyste- inemia, oxidative stress, and cerebral vas- cular dysfunction. Stroke 2004;35:345-7.
  6. Chia S, Wilson R, Ludlam CA, Webb DJ, Flapan AD, Newby DE. Endothelial dys- function in patients with recent myocar- dial infarction and hyperhomocysteinae- mia: effects of vitamin supplementation. Clin Sci (Lond) 2005;108:65-72.

Cited by

Sorted by citations

Authors
Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., & Rasmussen, K.
Affiliations
  • UiT The Arctic University of Norway (NO)
  • University of Bergen (NO)
  • Norwegian Institute of Public Health (NO)
  • University Hospital of North Norway (NO)
  • Haukeland University Hospital (NO)
Venue
New England Journal of Medicine
Published
2006-04-13
Volume
354
Issue
15
Pages
1578-1588
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2115135910
Cited by
1,442
References
41
Citations by year
2026: 22 · 2025: 25 · 2024: 27 · 2023: 29 · 2022: 17 · 2021: 25 · 2020: 28 · 2019: 26 · 2018: 33 · 2017: 49 · 2016: 48 · 2015: 52 · 2014: 61 · 2013: 68 · 2012: 97
FWCI
134.58
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Universitetet i Tromsø
  • European Society of Cardiology
  • Norges Forskningsråd
  • Helse Nord RHF
Topics
  • Health Sciences › Medicine › Rheumatology › Folate and B Vitamins Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
Keywords
homocysteine, acute myocardial infarction, B vitamins, folic acid, vitamin B12, vitamin B6, secondary prevention, cardiovascular events, reinfarction, stroke, sudden cardiac death, hyperhomocysteinemia
MeSH terms
Adult, Aged, Aged, 80 and over, Double-Blind Method, Drug Therapy, Combination, Female, Folic Acid, Humans, Male, Middle Aged, Myocardial Infarction, Vitamin B 12, Proportional Hazards Models, Death, Sudden, Cardiac, Hyperhomocysteinemia, Stroke, Vitamin B 6, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review